Symposium 1985
QUB delegates travelling early to Dublin
TTMI's Durkan Lecture Theatre hosted the symposium
Tomas Adell, Director of Elective Care and Cancer Policy
Symposium Discussion 2 Session
Prof. Maeve Lowery, Academic Director of the Trinity Centre Cancer Institute
Ms. Lorraine Smith, AllCaN Oesophageal PhD Candidate
Ms Orla Dolan, CEO Breakthrough Cancer Research
Prof. Helen Coleman, AllCaN Oesophageal Co-Lead
Dr Declan Soden, CEO Mirai Medical
Dr. Richard Turkington, AllCaN Oesophageal PI
The Oesophageal Cancer Fund (OCF) Team: Carmel Doyle (CEO), Dervilla Downey (Accounts & Data Manager), Noelle Ryan (Founder) and Sharon Cooney (Lollipop Day Coordinator)
The AllCaN Oesopahgeal Symposium 2024 Programme

The All-Ireland Cancer Network (AllCaN) Oesophageal Symposium took place in the Durkan Lecture Theatre, Trinity Translational Medicine Institute, Trinity College Dublin, St. James's Hospital (Dublin) on 23rd October 2024. The symposium aimed to address challenges and advancements in the understanding, prevention, diagnosis, and treatment of Barrett’s oesophagus and oesophageal cancer while fostering the collaboration and the exchange of insights amongst clinicians, scientists and patient advocates from across the island of Ireland. As a joint initiative across Northern Ireland and the Republic of Ireland, AllCaN Oesophageal strives to unify research and clinical practices in oncology, with a particular focus on patient-centred solutions. The symposium structured discussions around AllCaN Oesophageal's four core work packages: Prevention, Intervention, Targeted Diagnostics, and Novel Therapeutics, providing a comprehensive look at current research and development efforts in Barretts Oesophagus oesophageal cancer care.

Prof. Jacintha O'Sullivan (AllCaN Oesophageal Leader), Ms Orla Dola (CEO Breakthrough Cancer Research), Prof. Helen Coleman (AllCaN Oesophageal Co-Lead) and Dr Frances Drummond (Research Manager, Breakthrough Cancer Research).
AllCaN

If you would like to contact AllCaN Oesophageal, please get in contact with us